Follicular Lymphoma Foundation
Jess Burley is an accomplished professional with extensive experience in leadership and board roles across various organizations. Currently serving as the Future Tech Chair and Global CEO at MSIX&Partners, as well as holding positions as a Partner and Exec Chair, Jess also contributes as a Board Trustee at the Follicular Lymphoma Foundation and is a member of the Mindshare Global Exco Committee. Previous roles include Senior Independent Director at The Quarto Group, Non Executive Director at UK Mail PLC, Jacques Vert PLC, and Talk Talk Group PLC, and Director at the Audit Bureau Circulation. Jess's early career included the position of Managing Director at the National Magazine Company. Educational background includes a BA Hons in English Literature & Theatre Arts from the University of the West of England.
This person is not in the org chart
This person is not in any teams
Follicular Lymphoma Foundation
The Follicular Lymphoma Foundation is the first organisation in the world dedicated solely to finding new treatments and cures for follicular lymphoma. Follicular lymphoma is a currently incurable blood cancer. The FLF was founded by Nicola Mendelsohn three years after her diagnosis with the disease and is focused on funding and facilitating work that will take new treatments and cures for the disease from bench to bedside in the quickest possible timeframe. We are doing this by disrupting and challenging the current thinking on how to find a cure for this disease, by mobilising patients and investing in the most promising scientific and research discovery approaches.